Latest & Important News About: Cipla
Nomura on Cipla
Nomura on Cipla Buy, TP Rs 1195 Goa USFDA inspection: 3 repeat observations As a base case, do not expect inspection outcome to have a material impact on earnings est Have not factored any material contribution from gAbraxane in est, as there are uncertainty over generic approval
Jefferies on Cipla
Jefferies on Cipla Buy, TP raised to Rs 1223 Upcoming launches & pipeline look strong; several high-value products likely to be launched in next 6-9m A review of inhaler & peptide space indicates both are less chartered territories by generics where co has US filings Buy, TP raised to Rs 1223 Revise US sales & […]
Recent Comments